Results

Total Results: 398 records

Showing results for "psa".
Users also searched for: aspirin

41. Localized Prostate Cancer | Effective Health Care
    effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/05.html
    June 08, 2018 - For those men that choose screening, two tests that may be used to detect prostate cancer are: PSA … blood test: A blood test that detects a protein, called prostate-specific antigen (PSA), made by the … This test shows how much PSA is in your blood. … If your PSA levels are higher than normal or have increased over time, your doctor might test you for

42. Measures of Inefficiency | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/nhqrdr/chartbooks/careaffordability/measures3.html
    June 01, 2018 - Services Task Force recommended against screening men age 75 and over with prostate-specific antigen (PSA … Overall Rate: In 2014, 21.1% of men age 40 and over reported a PSA test in the past year (data not shown … Groups With Disparities: In 2014, men ages 40-54 were less likely to receive a PSA test in the past … Among men ages 40-54, Asians were less likely than Whites to receive PSA testing and Blacks were more … Among men age 75 and over, AI/ANs were less likely than Whites to receive PSA testing.

43. Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prostate-cancer-screening
    May 08, 2018 - Objective: To systematically review evidence on prostate-specific antigen (PSA)–based prostate cancer … Effectiveness of PSA-Based Screening Key Question 1. … What are the harms of PSA-based screening for prostate cancer and diagnostic follow-up? … Contamination in PLCO control group, and low adherence with single PSA screening in CAP. … ERSPC sites with variable PSA thresholds for positive test results.

44. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - clinically localized prostate cancer (CLPC) detected clinically rather than by prostate-specific antigen (PSA … to no mortality difference versus RP or external beam radiation (EBR)+androgen deprivation (AD) in PSA … ProtecT PSA-based active monitoring group is labeled active surveillance in figure. … Absolute effects are likely smaller among PSA-detected CLPC due to its more indolent course. … AM was compared with RP or EBR plus AD in PSA screen–detected CLPC.

45. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - clinically localized prostate cancer (CLPC) detected clinically rather than by prostate-specific antigen (PSA … to no mortality difference versus RP or external beam radiation (EBR)+androgen deprivation (AD) in PSA … ProtecT PSA-based active monitoring group is labeled active surveillance in figure. … Absolute effects are likely smaller among PSA-detected CLPC due to its more indolent course. … AM was compared with RP or EBR plus AD in PSA screen–detected CLPC.

46. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
    February 01, 2008 - We focused on baseline PSA levels and Gleason histologic score. … Prostate cancers not detected by PSA testing. … with PSA levels and rate of PSA rise … levels in men with PSA-detected disease. … PSA testing.

47. Archived: Prostate Cancer: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-1996
    January 01, 1996 - , 17 and its role in screening has largely been replaced by PSA. … PSA elevations are not specific for prostate cancer. … suggested that PSA density (the PSA concentration divided by the gland volume as measured by TRUS) may … Other studies suggest that the rate of change (PSA velocity), rather than the actual PSA level, is a … PSA screening for asymptomatic prostate cancer: truth in advertising.

48. 04-E029-1 Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - Two cohorts used PSA density (PSA per volume of prostate tissue) thresholds. … All seven cohorts in the PSA screening era included regular PSA testing. … screening era reported that PSA testing became part of followup protocol after PSA became available. … All six cohorts in the PSA screening era included regular PSA testing as part of followup protocol. … at diagnosis, decreased free-to-total PSA ratio, or more rapid PSA increase, but not comorbidities or

49. Archived: Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
    October 07, 2011 - group (50% received ≥1 PSA test). … Annual PSA for 6 y Annual DRE for 4 y PSA cut point >4.0 µg/L Positive … PSA previously >3.0 µg/L, a PSA increase of 20% over previous year's value or over predicted PSA … < 10 µg/L: 22% PSA 11–29 µg/L: 28% PSA > 30 µg/L: 23% PSA unknown: 27% Age, period of diagnosis, method … < 10 µg/L: 57%  PSA 10–20 µg/L: 26%  PSA > 20 µg/L: 11% PSA unknown: 13% Age at diagnosis, race/ethnicity

50. Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
    April 01, 2013 - Current AUA guidelines for PSA screening recommend another serum PSA when presented with an abnormal … values (PSA velocity) if available, free PSA if available, family history, race, etc. are considered … It is likely that tPSA and PSA density are correlated because tPSA is used in the calculation of PSA … serum PSA, this approach introduces the following issues: 1) PSA is used differently for repeat … PSA data.

51. Screening for Prostate Cancer: Clinical Summary (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/HUjbcP7uLa2SrGpVW4Fbhd
    August 07, 2008 - Insufficient Evidence) Men Age 75 Years or Older Do not screen Grade: D The prostate-specific antigen (PSA … The conventional PSA test cut-point of 4.0 g/L misses some early cancer. … Variations of PSA screening have not yet been demonstrated to improve health outcomes. … If PSA screening reduces mortality, screening every 4 years may be as beneficial as annual screening. … Interventions Clinicians should discuss the potential benefits and known harms of PSA screening with

52. PCA3 Testing for the Diagnosis and Management of Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research
    April 01, 2013 - Comparators included total prostate specific antigen (PSA) elevations, free PSA, PSA density, PSA velocity … , externally validated nomograms, complexed PSA, and multivariate models. … Comparison of PCA3 to total PSA (tPSA) had the most available studies (22) but was subject to spectrum

53. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
    March 01, 2013 - Thus, 14 articles were reviewed for PsA. … A new meta-analysis9 found PsA Response Criteria (PsARC) response at 12-14 weeks was significantly … This drug is not approved for PsA. … This drug is not approved for PsA. EPC Investigator felt the conclusions were up to date. … This drug is not approved for PsA. EPC Investigator felt the conclusions were up to date.

54. Localized Prostate Cancer | Effective Health Care
    effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/07.html
    June 08, 2018 - Your doctor will use your PSA level, Gleason Score, and tumor "T stage" to determine whether your cancer … Prostate Cancer Risk Groups Low Risk Low-risk cancer has PSA levels less than 10 ng/ml, Gleason … Intermediate/Medium Risk Medium-risk cancer has PSA levels of 10–20 ng/ml, Gleason Scores of 7, or … High Risk High-risk cancer has PSA levels of more than 20 ng/ml, Gleason Scores of 8 or higher, or

55. Prostate-Cancer-Therapies-Update Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
    December 01, 2014 - Comparative Effectiveness Review Number 146 a physical examination, prostate-specific antigen (PSA … Effective Health Care Program 2 The PSA test is used to measure blood levels of PSA, a protein produced … separating a “normal” PSA level from an abnormal level also remains a subject of debate. … PSA, PSA kinetics (rate of rise in PSA over time and doubling time for PSA), and digital rectal examination … cancer (especially low PSA/low-risk disease, but possibly intermediate PSA/intermediate-risk disease

56. Prostate Cancer Screening Recommendation Frequently Asked Questions (pdf file)
    www.uspreventiveservicestaskforce.org/Home/GetFileByID/3786
    October 09, 2018 - How to interpret the recommendation What is the PSA test? … The PSA test measures the amount of prostate-specific antigen, a type of protein, in a man’s blood. … When a man has an elevated PSA level, it may be caused by prostate cancer, but it could also be caused … What’s the harm in getting a PSA test? … It includes regular, repeated PSA testing and often repeated digital rectal examination and prostate

57. Prostate Cancer Screening Recommendation Frequently Asked Questions (pdf file)
    www.uspreventiveservicestaskforce.org/Home/GetFileByToken/-BbKrbuLt9RAPvf3BQrUMW
    October 09, 2018 - How to interpret the recommendation What is the PSA test? … The PSA test measures the amount of prostate-specific antigen, a type of protein, in a man’s blood. … When a man has an elevated PSA level, it may be caused by prostate cancer, but it could also be caused … What’s the harm in getting a PSA test? … It includes regular, repeated PSA testing and often repeated digital rectal examination and prostate

58. Comparative Effectiveness of Drug Therapy for Psoriatic Arthritis in Adults – An Update to the 2007 Report | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/arthritis-psoriatric/research-protocol
    December 06, 2010 - PDF 729.3 KB Background and Objectives for the Systematic Review Psoriatic arthritis (PsA … PsA has a highly variable presentation, which generally involves pain and inflammation in joints and … Additionally, PsA may predate the development of skin disease leading to some diagnostic uncertainty. … In the general population the prevalence of PsA is estimated to be 0.3% to 1%. … Treatment of psoriatic arthritis (PsA) aims to control pain and inflammation and, ultimately, to slow

59. U.S. Preventive Services Task Force Seeks Comments on Draft Recommendation Statement on Screening for Prostate Cancer (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/prostate-cancer-draft-bulletin.pdf
    April 03, 2017 - For men ages 70 years and older, the potential benefits of PSA-based screening do not outweigh the … (D recommendation) Visit www.screeningforprostatecancer.org for more information The PSA test … When a man has an elevated PSA, it may be caused by prostate cancer, but it could also be caused by … PSA-based screening and follow-up prostate biopsies cannot tell for sure which cancers are likely to … based in part on new evidence on the use of active surveillance, which includes regular, repeated PSA

60. Treating Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/consumer
    January 21, 2016 - PSA blood test: This blood test tells how much PSA (a protein made by the prostate gland) is in your … Many men with prostate cancer have PSA levels that are higher than normal or that have gotten higher … A high PSA level does not always mean a man has prostate cancer. … This growth, and other health conditions, can cause a high PSA level in men who do not have prostate … Determining risk level Risk Level* PSA Level Gleason Score T-Score * From the 2015 clinical